+499.5%
MRNA vs RBRK
+6.4%
+493.0%
-34.2%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 1y.
| Period | Portfolio | RBRK | Excess | Alpha |
|---|---|---|---|---|
| 1D | -2.2% | +1.7% | -3.9% | -2.5% |
| 7D | +5.5% | +0.7% | +4.8% | +5.2% |
| 30D | +158.7% | +10.4% | +148.3% | +150.1% |
| 3M | +182.1% | +21.6% | +160.5% | +166.9% |
| 6M | +151.8% | +70.7% | +81.1% | +118.6% |
| YTD | +393.6% | +22.5% | +371.1% | +364.8% |
| 1Y | +499.5% | +8.2% | +491.2% | +464.2% |
| All | +499.5% | +6.4% | +493.0% | +464.2% |
Cumulative growth
Daily Returns
Daily percentage return beside RBRK.
Daily Out/Under-Performance
Portfolio return minus RBRK return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × RBRK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 1y: compounded portfolio wealth divided by compounded RBRK wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
1y analysis · Full analysis span regression · 6 months rolling